EPIDEMIOLOGY OF VIRAL HEPATITIS AND HEPATOCELLULAR CARCINOMA

Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBVor HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States.

[1]  Y. Liu,et al.  Tumour Necrosis Factor-α Polymorphisms and Hepatocellular Carcinoma: A Meta-analysis , 2010 .

[2]  B. McMahon,et al.  Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. , 1990, Archives of internal medicine.

[3]  H. El‐Serag,et al.  Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. , 2008, American journal of epidemiology.

[4]  X. Shen,et al.  Tumour necrosis factor 308 polymorphisms and hepatocellular carcinoma risk: a meta-analysis. , 2010, Hepato-gastroenterology.

[5]  M. Mizokami,et al.  Molecular Evolution of Hepatitis Viruses , 1999, Intervirology.

[6]  L. Lai,et al.  Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy. , 1997, The Western journal of medicine.

[7]  K. Yoo,et al.  Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis , 2011, International journal of cancer.

[8]  P. Simmonds,et al.  Association between chronic hepatitis C infection and hepatocellular carcinoma , 1995, The Lancet.

[9]  M. Alter,et al.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. , 2010, Gastroenterology.

[10]  Ding‐Shinn Chen,et al.  Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.

[11]  P Boffetta,et al.  A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.

[12]  C. la Vecchia,et al.  Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis , 2007, Hepatology.

[13]  P. Boffetta,et al.  Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Meta-analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[14]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[15]  H. Margolis,et al.  Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. , 1998, The Journal of infectious diseases.

[16]  Chien-Jen Chen,et al.  Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Manal M. Hassan,et al.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. , 2009, Journal of hepatology.

[18]  Chun-Jen Liu,et al.  Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. , 2011, Carcinogenesis.

[19]  P. Pontisso,et al.  HCV-associated liver cancer without cirrhosis , 1995, The Lancet.

[20]  B. Henderson,et al.  A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China , 1995, International journal of cancer.

[21]  F. Carrat,et al.  Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. , 2006, Journal of hepatology.

[22]  I. Hung,et al.  Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma , 2011, Hepatology.

[23]  M. Woodward,et al.  Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. , 2009, Archives of internal medicine.

[24]  Y. Jeng,et al.  Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. , 2004, Gastroenterology.

[25]  H. El‐Serag,et al.  The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans , 2001, American Journal of Gastroenterology.

[26]  S. Larsson,et al.  Coffee consumption and risk of liver cancer: a meta-analysis. , 2007, Gastroenterology.

[27]  Ding‐Shinn Chen,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level , 2007 .

[28]  S. Porru,et al.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.

[29]  K. Chayama,et al.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. , 1998, Journal of hepatology.

[30]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[31]  Angelique Zeringue,et al.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.

[32]  M. Lai,et al.  Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection , 2006, Hepatology.

[33]  S. Taylor-Robinson,et al.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. , 2008, World journal of gastroenterology.

[34]  J. Samet,et al.  Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. , 2004, Journal of the National Cancer Institute.

[35]  T. Therneau,et al.  Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  Ding-Shinn Chen,et al.  Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. , 2006, The Journal of infectious diseases.

[37]  H. El‐Serag,et al.  Higher serum testosterone is associated with increased risk of advanced hepatitis C–related liver disease in males , 2012, Hepatology.

[38]  Chien-Jen Chen,et al.  Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. , 2010, Gastroenterology.

[39]  Mei-Hwei Chang,et al.  Hepatitis B virus and cancer prevention. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[40]  Pei-Jer Chen,et al.  Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones , 2010, Oncology.

[41]  Ai-Jun Li,et al.  Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. , 2010, Journal of hepatology.

[42]  Chien-Jen Chen,et al.  Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[44]  Shiyuan Liu,et al.  A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.

[45]  C. J. Chen,et al.  Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. , 2000, Journal of the National Cancer Institute.

[46]  Oliver N Keene,et al.  Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.

[47]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[48]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[49]  M. Mondelli,et al.  Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.

[50]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[51]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[52]  H. El‐Serag,et al.  The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? , 2003, American Journal of Gastroenterology.

[53]  J. Kaldor,et al.  Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.

[54]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[55]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[56]  S. Mano,et al.  Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. , 2006, Gastroenterology.